10.Literaturverzeichnis

1. Anderson CB, Philpott GW, Ferguson TB: The treatment of malignant pleural e f fusions. Cancer 33 (1974) 916-22

2. Andrews CO, Gora ML: Pleural effusions: pathophysiology and management. Ann Pharmacother 28 (1994) 894-903

3. Antony VB, Mohammed KA: Pathophysiology of pleural space infections. Semin Respir Infect 14 (1999) 9-17

4. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, Rodriguez Panadero F, Sahn SA: ERS/ATS statement: Management of malignant pleural e f fusions. Eur Respir J 18 (2001) 402-19

5. Antunes G, Neville E, Fuffy J, Ali N: On behalf of the BTS Pleural Disease Group, a subgroup of the BTS Standards of Care Committee: BTS guidelines for the management of malignant pleural effusion. Thorax 58 [Suppl II] (2003) :II29-II38

6. Belani CP, Pajeau TS, Bennett CL: Treating malignant pleural effusions cost co n sciously. Chest 113 (1998)78-85

7. Bethune N: Pleural poudrage: a new technic for the deliberate production of ple u ral adhesions as a preliminary to lobectomy. J Thorac Surg 4 (1935) 251-61

8. Böck D: Neue zytomorphologische Ergebnisse bei lokaler Behandlung des karz i nomatösen Pleuraergusses. Krebsgeschehen 2 (1983) 33-34

9. Bullinger M: Gesundheitsbezogene Lebensqualität und subjektive Gesundheit. Psychoth Psychosom med Psych 47 (1997 ) 76-91

10. Burrows CM, Mathews WC, Colt HG: Predicting survival in patients with recu r rent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest. 117(1) (2000) 73-80

11. Canto A, Gijarro R, Arnau A: Videothoracoscopy in the treatment of malignant pleural mesothelioma with associated pleural effusions. Thor Cardiovasc Surg. 45 (1997) 16-19

12. Cardillo G, Facciolo F, Carbone L, Regal M, Corzani F, Ricci A, Di Martino M, Martelli M: Long-term follow-up of video-assited talc pleurodesis in malignant r e current pleural effusions. Eur J Cardiothorac Surg 21 (2002) 302-5

13. Chan K, Tan KL, Lee HS: Malignant mesothelioma: experience at the Hospital. Ann Acad Med Singapore 32 (2003) 388-91

14. Charvat JC, Brutsche M, Frey JG: Stellenwert der Thorakoskopie in der Diagno s tik und palliativen Behandlung maligner pleuraler Mesotheliome. Schweiz Rundsch Med Prax 87 (1998) 336-40

15. Colt H, Russack V, Chiu Y, Konopka R, Chiles P, Pedersen C: A comparison of thorakoskopic talc insufflation, slurry and mechanical abradion pleurodesis. Chest 111 (1997) 442-48

16. Culine S, Kramar A, Saghatchian M, Bugat R, Lesimple T, Lotholary A: Develo p ment and validation of a prognostic model to predict the length of survival in p a tients with carcinoma of an unknown primary site. J Clin Oncol 20 (2002) 4679-83

17. Danby C A, Adebonojo SA, Moritz DM: Videoassisted talc pleurodesis for mal i gnant pleural effusions utilizing local anaestesia and i.v.sedation. Chest 113 (1998) 739-42

18. De Camp MM, Mentzer SJ, Swanson SJ, Sugarbaker DJ: Malignant effusive di s ease of the pleura and pericardium. Chest 112 (1997) 291-95

19. Deppermann K, Kreuser E: Therapie maligner Pleuraergüsse. In: Schmoll, Höff-ken, Possinger : Kompendium der internistischen Onkologie, 2. Auflage, Springer Verlag (1996) 1852-64

20. Engel J, Hölzel D, Kerr J: Die Epidemiologie. Manual der Mammakarzinome. T u morzentrum München. Zuckschwerdt Verlag München 2003

21. Fenton KN, Richardson JD: Diagnosis and management of malignant pleural eff u sions. Am J Surg 170 (1995) 69-74

22. Furrer M, Inderbitzi R: Pleurodeseverfahren beim malignen Pleuraerguss. Schweiz Med Wochenschr 122 (1992) 181-88

23. Genc O, Petroum, Ladas G: The long time morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur J Cardiothorac Surg 18 (2000) 143-46

24. Gompel C, Silverberg SG: Pathologie in Gynecologie and Obstetrics. 4th ed i tion. JB Lippincott Company , Philadelphia 1994

25. Grossi F, Pennucci MC, Tixi L, Cafferata MA, Ardizzoni A: Management of mali g nant pleural effusions. Drugs 55 (1998) 47-58

26. Groth G, Gatzemeier U, Haussingen K, Heckmayr M, Magnussen H, Neuhauss R, Pavel JV: Intrapleural palliative treatment of malignant pleural effusions with m i toxantrone versus placebo (pleural tube alone). Ann Oncol 2 (1991) 213-15

27. Guerin JC, Boniface E: Pleurodesis technics. Rev Prat 40 (1990) 1854-56

28. Gust R, Fabel H: Fibrin glue pleurodesis in recurrent malignant pleural effusions. Pneumologie 43 (1989) 85-87

29. Gust R, Kleine P, Fabel H: Fibrin glue and tetracycline pleurodesis in recurrent malignant pleural effusions. A randomized comparative study. Med Klin 85 (1990) 18-23

30. Hausheer FH, Yarbro JW: Diagnosis and treatment of malignant pleural eff u sion. Semin Oncol 12 (1985) 54-75

31. Hentrich M, Hartenstein R: Treatment of malignant effusions in body cavities. Internist (Berl) 38 (1997) 794-804

32. Hübner G, Tamme C, Wildfang I, Schöber C, Schmoll HJ: Management of p a tients with carcinoma of unknown primary (CUP). J Canc Res Clin Onc 116 (1990) 505-15

33. Inderbitzi R, Rolle A: Chirurgische Palliation im Thoraxbereich bei primären und sekundären Malignomen. Therapeutische Umschau 58 (2001) 435-41

34. Johnston WW: The malignant pleural effusion. A review of cytopathologic diagn o ses of 584 specimens from 472 consecutive patients. Cancer 56 (1985) 905-9

35. Kaiser D: Operative Therapie des Bronchialkarzinoms. In: Loddenkemper, R, (Hrsg) Das Bronchialkarzinom und andere pulmonale Tumoren. W. Kohlha m mer GmbH Stuttgart, Berlin, Köln ( 1968) 94-131

36. Kaiser D, Maassen W, Greschuchna, D : Recommendations on diagnosis, stagi n gand surgical therapy of lung cancer.Thorac Cardiovasc Surg 36 ( 1988 ) 295-306

37. Kaiser D, Ennker, IC, Hartz, C : Video-assisted thoracoscopic surgery-indications, results, complications and contraindications. Thorac Cardiovasc Surg 41 (1993) 330-334

38. Krisman M, Pieper K, Müller KM: Pleurale Reaktionsmuster nach Talkum-Pleurodese. Pathologe 19 (1998) 214-20

39. Kreuser ED: Maligne Pleuraergüsse. Dtsch Med Wochenschr 110 (1985)1381-6

40. Kreuser ED, Seifried E, Harsch U, Brass B, Schreml W, Heimpel H: Fibrinpleur o dese bei malignen Plauraergüssen. Dtsch Med Wochenschr 110 (1985) 1365-8

41. Kvale G, Heuch I, Nilsen S: Reproductive factors and risk of ovarian cancer. Int J Cancer 42 (1989) 246

42. Kvale PA, Simmoff M, Prakash UB: Lung cancer. Palliative care. Chest 123 (2003) 284-311

43. Leschber G: Pleuraerguss – Therapieoptionen bei Patienten mit Lungen-karzinom, Journal Onkologie online, Ausgabe 02/04

44. Light RW, Mac Gregor MI, Luchsinger PC, Ball WC: Pleural effusions: the dia g nostic separation of transudates and exudates. Ann Intern Med 77 (1972) 507-13

45. Light RW: Pleural diseases. Lea & Febiger Philadelphia (1990)

46. Light RW, Vargas FS: Pleural sclerosis for the treatment of pneumothorax and pleural effusion. Lung 175 (1997) 213-23

47. Loddenkemper R: Diagnostik der Pleuraergüsse. Dtsch Med Wochenschr 117 (1992) 1487-91

48. Loddenkemper R, Frank W : Therapie der Pleuraergüsse. Dtsch Med Wochenschr 117 (1992) 1527-31

49. Loddenkemper R, Boutin C: Thorakoskopie: aktuelle diagnostische und thera-peutische Indikationen. Pneumologie 50 (1996) 189-201

50. Love D, White D, Kiroff D: Thoracoskopic talc pleurodesis for malignant pleural e f fusion. ANZ J Surg. 73 (2003) 19-22

51. Lynch TJ : Management of malignant pleural effusions. Chest 103 (1993) 385-89

52. Martin-Diaz E, Arnau-Obrer A, Martorell-Cebollada M: Thoracocentesis for the a s sessment of lung cancer with pleural effusion. Arch bronchopneumol 38 (2002) 479-84

53. Merritt N, Blewett CJ, Miller JD:. Survival after palliative management of pleural malignant mesothelioma. J Surg Oncol. 78 (2001) 171-4

54. Miles DW, Knight RK: Diagnosis and management of malignant pleural eff u sion. Cancer Treat Rev 19 (1993) 151-68

55. Miserocchi G: Physiology and pathophysiology of pleural fluid turnover. Eur Respir J. 10 (1997) 2-3

56. Moffett MJ, Ruckdeschel JC: Bleomycin and tetracycline in malignant pleural eff u sions: a review. Semin Oncol 19 (1992) 59-62

57. Moores DW: Malignant pleural effusion. Semin Oncol 18 (1991) 59-61

58. Muir C: Cancer of unknown primary site. Cancer 75 (1995) 353-356

59. Naruke T, Tsuchiya R, Kondo H, Asamura H : Prognosis and survival after rese c tion for bronchogenic carcinoma based on the 1997 TNM-staging classification: The Japanese experience. Ann Thorac Surg 71 ( 2001 ) 1759-64

60. Nasreen N, Mohammed KA, Dowling PA : Talc induces apoptosis in human mali g nant mesothelioma cells in vitro. Am J Respir Crit Care Med. 161 ( 2000) 595-600

61. Paladine W, Cunningham TJ, Sponzo R, Donavan M, Olson K, Horton J: Intr a cavitary bleomycin in the management of malignant effusions. Cancer 38 (1976) 1903-8

62. Patel MC, Flower CD: Radiology in the management of pleural disease. Eur Radiol 7 (1997) 1454-62

63. Pien GW, Gant MJ, Washam CL, Sterman DH: Use of an implantable pleural catheter for trapped lung syndrome in pathients with malignant pleural effusion. Chest 119 (2001) 1641-46

64. Petrou M, Kaplan D, Goldstraw P : Managment of recurrent malignant pleural eff u sion. The complimentary role of pleurodesis and pleuroperitoneal shunting. Cancer. 75 (1995) 801-5

65. Putnam J, Walsh G, Swisher S, Roth J: Outpatient Management of malignant pleural effusion by chronic indwelling pleural catheter. Ann Thorac Surg 69 (2000) 369–75

66. Putnam J, Light R, Rodriguez R, Ponn R, Olak J, Pollak J, Lee R, Payne D, Gra e ber G, Kovitz K: A randomized comparison if indwelling pleural catheter and dox y cycline pleurodesis in the management of malignant pleural effusions. Cancer 86 (1999) 1992-9

67. Pollak J: Malignant pleural effusions: treatment with tunneled long-term drai n age catheters. Curr pulm med 8 (2002) 302-7

68. Rodriguez-Panadero A: Pleurodesis: state of the art. Eur Respir J 10 (1997) 1648-54

69. Rodriguez-Panadero F: Low glucose and pH levels in malignant pleural eff u sions: diagnostiv significance and prognostic value in respect to pleurodesis. Am Rev Respir Dis 139 (1989) 663-7

70. Ruckdeschel JC, Moores D, Lee JY, Einhorn LH, Mandelbaum I, Koeller J, Weiss GR, Losada M, Keller JH: Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest 100 ( 1991) 1528-35

71. Sahn SA: Management of malignant pleural effusions. Monaldi Arch Chest Dis 56 (2001) 394-9

72. Sahn SA: Pleural diseases related to metastatic malignancies . Eur Respir J 10 (1997) 1907-13

73. Sahn SA: State of the art. The pleura. Am Rev Respir Dis 138 (1988) 184-234

74. Sanchez-Armengol A, Rodriguez-Panandero F: Survival and talk pleurodesis in metastatic pleural carcinoma, revisited. Chest 104 (1993) 1482-5

75. Schafers SJ, Dresler CM : Update on talc, bleomycin, and the tetracyclines in the treatment of malignant pleural effusions. Pharmacotherapy 15 (1995) 228-35

76. Schmidt M: Therapie maligner Pleuraergüsse. In: Seeber, Schütte (Hrsg) Therapiekonzepte Onkologie, 3. Auflage, Springer Verlag 1998, 1355-63

77. Schulze M, Boehle AS, Kurdow R: Effective treatment of malignant pleural eff u sion by minima invasive thoracic surgery. Thoracoscopic talk pleurodesis and pleuroperitoneal shunt in 101 patients. Ann Thor Surg. 71 (2001) 1809-12

78. Senn HJ, Drings P, Glans A: Onkologie. 4 Auflage. Thieme Verlag. 1998

79. Shields T: Anatomy of the pleura. General Thoracic Surgery, Williams and Wilkens, Baltimore 1994, 31-5

80. Shoji T, Tanaka F, Yanagihara K, Inui K, Wada H: Phase II study of repeated i n trapleural chemotherapy using implantable access system for management of m a lignant pleural effusion. Chest 121 (2002) 821-4

81. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi, Stepherd R, Battista RN, Catchlove BR: Measering the quality of live of cancer patients. J Chronic Dis (1981) 523-8

82. Starling E, On the absorption of fluids from the connective tissue spaces. J Physiologie 19 (1898) 312

83. Sterman D, Kruklitis R, Lund M, Musani A: Pleurodesis for the therapie of mali g nant pleural effusions – Should it be an inpatient procedure? Con. Inpatient pr o cedure. J Bronch 10 (2003) 218-22

84. Sterman D, Kaiser LR, Albelda SM. Advances in the treatment of malignant ple u ral mesothelioma. Chest 116 (1999) 504-20

85. Talerman A: Ovarian Pathology. Cur Op Obst Gyn 4 (1992) 608-15

86. Tattersall M:. Pleural effusions. Curr Opin Oncol 4 (1992) 642-6

87. Thomas M, Baumann M, Deppermann M, Freitag L, Gatzemeier U, Huber R, Paslick B, Serke M, Ukena F: Empfehlungen zur Therapie des Bronchial-karzinoms. Pneumologie 56 (2002) 113-31

88. Türler A, Walter M, Schmitz-Rixen T: Current treatment strategy in malignant pleural effusion. Wien Klin Wochenschr 108 (1996) 255-61

89. Ullmer E, Wyser C, Soler M: Pleuraerguss: wie weiter?. Schweiz Med Wochenschr 128(1998) 451-8

90. Van de Wouw AJ, Jansen RL, Speel EJ, Hillen HF: The unknown biology of the unknown primary Tumour: a literature review. Ann Onc 14 (2003) 191-96

91. Viallat JR, Rey F, Astoul P, Boutin C: Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases .Chest 110 (1996) 1387-93

92. Walker-Renard PB, Vaughan LM, Sahn SA: Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 120 (1994) 56-64

93. Walter M, Turler A, Schmitz-Rixen T: Talc pleurodesis in recurrent malignant ple u ral effusion - a prospective follow-up study. Zentralbl Chir 121 (1996) 216-22

94. Weissberg D, Ben-Zeev I: Talc pleurodesis. Experience with 360 p a tients.Thorac Cardiovasc Surg 106 (1993) 689-95

95.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
07.09.2006